|
|
|
Corporate Profile: Syndax Pharmaceuticals
| Summary: |
Syndax Pharmaceuticals is focused on epigenetic modification of the tumor phenotype to allow expression of suppressed signaling pathways that restore sensitivity to standard therapy.
|
| Address (HQ): |
460 Totten Pond Road
Suite 650
Waltham, MA 02451 |
| Phone #'s (HQ): |
| Main |
(781) 419-1400 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(781) 419-1420 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
